Ajax Therapeutics
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Ajax Therapeutics is a company in biotechnology, life science, medical based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2019.
Its activity falls under biotechnology, life science, medical; the profile below is assembled from public directory data.
The company is recorded as being based in Greater Boston Area, East Coast, New England, Northeastern US.
Its current recorded stage is Series_C.
Recorded headcount: c_00001_00010 employees.
Public records show total funding of about $143M.
| Sector | Biotechnology, Life Science, Medical |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | series_c |
| Total funding | $143,000,000 |
Website: www.ajaxtherapeutics.com
Sign in to view the contact information we hold for Ajax Therapeutics.
Create a free account
Create a free account